Association between polycystic ovary and fibrocystic breast by ultrasound
Keywords:
fibrocystic disease, breast, PCOS, patient, ultrasoundAbstract
Background: Polycystic ovary syndrome is one of the most gynecologic, endocrine cases affect approximately 5-15%of women during reproductive age. Polycystic ovary syndrome (PCOS) is a multifactorial and polygenic pathology that manifests itself with a wide spectrum of signs and symptoms. The study aims to find out the association between PCOS and fibrocystic disease of the breast according to finding detected by ultrasound. Method: Across sectional study with 140 patients were enrolled in this study collected from the gynecologic and infertility clinic in Al-Imameen Al-Kadhymian Medical City, Iraq, Baghdad during the period from march 2021 to January 2022.Information was taken from patients through interview, inclusion criteria includes female gender, age between 20-50 years old not using oral contraceptive drug, pelvic and breast ultrasound report. SPSS version 24 was used to examine the frequency association between variable. Result: There were 140 female cases of PCOs, fifty-five (39%) were fibrocystic disease of breast. The prevalence of fibrocystic disease of breast in patient with PCOs in current study were fifty-five (39%).there were significant association between fibrocystic disease of breast with age, education level, BMI, age of monarch, hirsutism, history of infertility and history of pain with p value ≤ 0.05.
Downloads
References
Pembe AB, Abeid MS. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania. Tanzan J Health Res. 2009;11(4):175-180.
Rajashekar JL, Krishna D, Patil M. Polycystic ovaries and infertility: Our experience. Hum Reprod Sci 2008;1:65–72.
Walters KA, Gilchrist RB, Ledger WL et al. New perspectives on the pathogenesis of PCOS: Neuroendocrine origins. Trends Endocrinol Metab 2018; 29: 841–852
Sullivan, S.D. and Moenter, S.M Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci U. S. A. 2004; 101: 7129–7134
Herbison AE, Moenter SM. Depolarising and hyper- polarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: Towards an emerging consensus. J. Neuroendocrinol 2011; 23: 557–569.
Diamanti-Kandarakis E, Kouli C, Alexandraki K et al. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clinl Endocrinol Metab 2004; 89: 1273–1276
Lobo RA: A disorder without identity: ‘HCA’, ‘PCO’, ‘PCOD’, ‘PCOS’, ‘SLS’. What are we to call it? Fertil Steril 1995;63:1158.
( Balen AH, Conoway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS: Polycystic ovary syndrome: The spectrum of the disorder in 1,741 patients. Hum Reprod 1995; 10:2107–2111.
Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA: Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 1997;12:905–909.
Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can. 2008;30(8):671-679.
Abdel Gadir A, Katim MS, Mowafi R: Implications of ultrasonically diagnosed polycystic ovaries. 1. Correlation with basal hormone profiles. Hum Reprod 1992;7:453–457.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012; 27:3067–73.
Johnson TRB, Kaplan LK, Ouyang P, Rizza RA. Evidence-based methodology workshop on polycystic ovary syndrome. https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf. Accessed October, 2015
Barbour, L.A., Shao, J., Qiao, L., Pulawa, L.K., Jensen, D.R., Bartke, A., Garrity, M., Draznin, B., and Friedman, J.E., 2002. Human placental growth hormone causes severe insulin resistance in transgenic mice. American journal of obstetrics and gynecology, 186 (3), pp.512-517.,
Kumarapeli, V., Seneviratne, R.D.A., Wijeyaratne, C.N., Yapa, R.M.S.C. and Dodampahala, S.H. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. American journal of epidemiology, 2008, 168 (3), pp.321-328. 3,
Aziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., EscobarMorreale, H.F., Futterweit, W., Janssen, O.E., Legro, R.S., Norman, R.J., Taylor, A.E. and Witchel, S.F., 2006. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. The Journal of Clinical Endocrinology & Metabolism, 91 (11), pp.4237-4245
Mehrabian, F., Khani, B., Kelishadi, R. and Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynologia Polska, 2011, 62 (3), pp.238-242.
McMullen ER, Zoumberos NA, Kleer CG. Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations. Arch Pathol Lab Med. 2019 Dec;143(12):1492-1496.
Santen RJ. Benign Breast Disease in Women. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; May 25, 2018.
Gorins A, Denis C. Effects of progesterone and progestational hormones on the mammary gland. Arch Anat Cytol Pathol 1995;43:28–35
Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019 May;34(5):499-507.
Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol. 1991;134(8):818–824.
Kim J, et al. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case–control study. Cancer Causes Control. 2016;27(3):403–414.
Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update. 2001;7(6):522–525.
Gumus II, Koktener A, Dogan D, Turhan NO. Polycystic ovary syndrome and fibrocystic breast disease: Is there any association? Arch Gynecol Obstet 2009;280:249–253
D’Amelio R, Farris M, Grande S et al. Association between polycystic ovary and fbrocystic breast disease. Gynecol Obstet Invest 2001; 51: 134–137
Pathak, D., Pike, M., Key, C. et al. Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series. Br J Cancer, 1991, 63, 1005–1009.
La Vecchia C, Decarli A, di Pietro S, Franceschi S, Negri E, Parazzini F. Menstrual cycle patterns and the risk of breast disease. Eur J Cancer Clin Oncol. 1985 Apr;21(4):417-22.
FABIO PARAZZINI, CARLO LA VECCHIA, SILVIA FRANCESCHI, ADRIANO DECARLI, GIUSEPPE GALLUS, MICHELA REGALLO, ALESSANDRO LIBERATI, GIANNI TOGNONI, RISK FACTORS FOR PATHOLOGICALLY CONFIRMED BENIGN BREAST DISEASE, American Journal of Epidemiology, Volume 120, Issue 1, July 1984, Pages 115–122,
FABIO PARAZZINI, CARLO LA VECCHIA, SILVIA FRANCESCHI, ADRIANO DECARLI, GIUSEPPE GALLUS, MICHELA REGALLO, ALESSANDRO LIBERATI, GIANNI TOGNONI, RISK FACTORS FOR PATHOLOGICALLY CONFIRMED BENIGN BREAST DISEASE, American Journal of Epidemiology, Volume 120, Issue 1, July 1984, Pages 115–122
Top 5 Diet Tips for Fibrocystic Breast Disease - Healthy U Turn, https://nutritionistoakville.com/top-5-diet-tips-for-fibrocystic-breast-disease-holistic-nutritionist-oakville/. Date accessed: 11/05/2022.
Ozkaya E, Cakir E, Cinar M, Kara F, Baser E, Cakir C, Kucukozkan T. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS? Gynecol Endocrinol. 2012 Jun;28(6):468-71.
Egwuonwu OA, Anyanwu SN, Chianakwana GU, Ihekwoaba EC. Breast Pain: Clinical Pattern and Aetiology in a Breast Clinic in Eastern Nigeria. Niger J Surg. 2016 Jan-Jun;22(1):9-11.
Fitzgibbons, P. L., Henson, D. E. & Hutter, R. V. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Archives of pathology & laboratory medicine 122, 1053–1055 (1998).
Longcope C, Kato T, Horton R. Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest. 1969 Dec;48(12):2191-201.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
